Company Listing
Avila Therapeutics

Avila developed medicines with the potential to improve patient outcomes in a fundamentally new way. Using a proprietary platform, Avila generated novel covalent drugs that bound irreversibly to specific disease-causing proteins, thereby 'silencing' them and eradicating the corresponding disease. The company was acquired by Celgene for up to $925 million in January 2012.

BACK
Location
Waltham, Massachusetts

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Avila developed medicines with the potential to improve patient outcomes in a fundamentally new way. Using a proprietary platform, Avila generated novel covalent drugs that bound irreversibly to specific disease-causing proteins, thereby 'silencing' them and eradicating the corresponding disease. The company was acquired by Celgene for up to $925 million in January 2012.

Location
Waltham, Massachusetts
BACK
 
Copyright Abingworth 2017